These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36102410)

  • 21. Gain-of-function STAT1 mutations are associated with intracranial aneurysms.
    Dadak M; Jacobs R; Skuljec J; Jirmo AC; Yildiz Ö; Donnerstag F; Baerlecken NT; Schmidt RE; Lanfermann H; Skripuletz T; Schwenkenbecher P; Kleinschnitz C; Tumani H; Stangel M; Pul R
    Clin Immunol; 2017 May; 178():79-85. PubMed ID: 28161409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanism and structural basis of gain-of-function of STAT1 caused by pathogenic R274Q mutation.
    Fujiki R; Hijikata A; Shirai T; Okada S; Kobayashi M; Ohara O
    J Biol Chem; 2017 Apr; 292(15):6240-6254. PubMed ID: 28258222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.
    Soltész B; Tóth B; Shabashova N; Bondarenko A; Okada S; Cypowyj S; Abhyankar A; Csorba G; Taskó S; Sarkadi AK; Méhes L; Rozsíval P; Neumann D; Chernyshova L; Tulassay Z; Puel A; Casanova JL; Sediva A; Litzman J; Maródi L
    J Med Genet; 2013 Sep; 50(9):567-78. PubMed ID: 23709754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis.
    Marom D; Offer I; Tamary H; Jaffe CL; Garty BZ
    Pediatr Hematol Oncol; 2001; 18(1):65-70. PubMed ID: 11205842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice.
    Tamaura M; Satoh-Takayama N; Tsumura M; Sasaki T; Goda S; Kageyama T; Hayakawa S; Kimura S; Asano T; Nakayama M; Koseki H; Ohara O; Okada S; Ohno H; Kobayashi M
    Int Immunol; 2020 Apr; 32(4):259-272. PubMed ID: 31867619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic Candida infection, bronchiectasis, immunoglobulin abnormalities, and stunting: a case report of a natural mutation of STAT1 (c.986C>G) in an adolescent male.
    Yu Y; Xu F; Shen H; Wu J
    BMC Infect Dis; 2021 Jan; 21(1):38. PubMed ID: 33413180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis.
    Bloomfield M; Zentsova I; Milota T; Sediva A; Parackova Z
    Front Immunol; 2022; 13():983977. PubMed ID: 36172362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemophagocytic lymphohistiocytosis as a manifestation of visceral leishmaniasis].
    Suková M; Starý J; Housková J; Nohýnková E
    Cas Lek Cesk; 2002 Sep; 141(18):581-4. PubMed ID: 12422569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation.
    Kobbe R; Kolster M; Fuchs S; Schulze-Sturm U; Jenderny J; Kochhan L; Staab J; Tolosa E; Grimbacher B; Meyer T
    Gene; 2016 Jul; 586(2):234-8. PubMed ID: 27063510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a distinct subset of disease-associated gain-of-function missense mutations in the STAT1 coiled-coil domain as system mutants.
    Petersen J; Staab J; Bader O; Buhl T; Ivetic A; Meyer T
    Mol Immunol; 2019 Oct; 114():30-40. PubMed ID: 31336247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report: Myocarditis in congenital STAT1 gain-of function.
    Staels F; Roosens W; Giovannozzi S; Moens L; Bogaert J; Iglesias-Herrero C; Gijsbers R; Bossuyt X; Frans G; Liston A; Humblet-Baron S; Meyts I; Van Aelst L; Schrijvers R
    Front Immunol; 2023; 14():1095595. PubMed ID: 37020552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation.
    Moriya K; Suzuki T; Uchida N; Nakano T; Katayama S; Irie M; Rikiishi T; Niizuma H; Okada S; Imai K; Sasahara Y; Kure S
    Int J Hematol; 2020 Aug; 112(2):258-262. PubMed ID: 32180118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).
    Zheng J; van de Veerdonk FL; Crossland KL; Smeekens SP; Chan CM; Al Shehri T; Abinun M; Gennery AR; Mann J; Lendrem DW; Netea MG; Rowan AD; Lilic D
    Eur J Immunol; 2015 Oct; 45(10):2834-46. PubMed ID: 26255980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Gain-of-Function Mutation in Stat1 Sumoylation Site Leads to CMC/CID Phenotype Responsive to Ruxolitinib.
    Al Shehri T; Gilmour K; Gothe F; Loughlin S; Bibi S; Rowan AD; Grainger A; Mohanadas T; Cant AJ; Slatter MA; Hambleton S; Lilic D; Leahy TR
    J Clin Immunol; 2019 Nov; 39(8):776-785. PubMed ID: 31512162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis: a case report.
    Ozyürek E; Ozçay F; Yilmaz B; Ozbek N
    Pediatr Hematol Oncol; 2005; 22(5):409-14. PubMed ID: 16020131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT1 Mutations in Chronic Mucocutaneous Candidiasis Diagnosed in an Adult.
    Andou M; Tominaga M; Nishikomori R; Gotoh K; Komatsu N; Matsuoka M; Kawayama T; Hoshino T
    Intern Med; 2024 May; 63(9):1269-1271. PubMed ID: 37779067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
    Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
    J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.
    Weinacht KG; Charbonnier LM; Alroqi F; Plant A; Qiao Q; Wu H; Ma C; Torgerson TR; Rosenzweig SD; Fleisher TA; Notarangelo LD; Hanson IC; Forbes LR; Chatila TA
    J Allergy Clin Immunol; 2017 May; 139(5):1629-1640.e2. PubMed ID: 28139313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pathogenic T387A missense mutation in the gene encoding signal transducer and activator of transcription 1 exhibits a differential gene expression profile.
    Staab J; Schwämmle T; Meyer T
    Mol Immunol; 2020 Dec; 128():79-88. PubMed ID: 33096415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal COVID-19 Infection in Two Children with STAT1 Gain-of-Function.
    Staines-Boone AT; Vignesh P; Tsumura M; de la Garza Fernández G; Tyagi R; Rawat A; Das J; Tomomasa D; Asano T; Hijikata A; Salazar-Gálvez Y; Kanegane H; Okada S; Reyes SOL
    J Clin Immunol; 2023 Dec; 44(1):20. PubMed ID: 38129739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.